MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Henry Schein Inc

Closed

Sector Healthcare

77.25 -0.92

Overview

Share price change

24h

Current

Min

76.98

Max

77.29

Key metrics

By Trading Economics

Income

99M

Sales

3.2B

P/E

Sector Avg

31.898

73.394

EPS

1.22

Profit margin

3.119

Employees

26,000

EBITDA

-43M

236M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+6.02 upside

Dividends

By Dow Jones

Next Earnings

25 Feb 2025

Market Stats

By TradingEconomics

Market Cap

-619M

9.7B

Previous open

78.17

Previous close

77.25

News Sentiment

By Acuity

35%

65%

109 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Henry Schein Inc Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jan 2025, 13:28 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

29 Jan 2025, 14:04 UTC

Top News
Acquisitions, Mergers, Takeovers

KKR Builds Stake in Medical-Supply Company -- 2nd Update

29 Jan 2025, 12:54 UTC

Acquisitions, Mergers, Takeovers

KKR Builds Stake in Medical-Supply Company -- Update

29 Jan 2025, 12:07 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

29 Jan 2025, 12:07 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

29 Jan 2025, 12:06 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

29 Jan 2025, 12:06 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 4Q Rev $3.2B >HSIC

29 Jan 2025, 12:03 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

29 Jan 2025, 12:03 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

29 Jan 2025, 12:02 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Names Robert Hombach an Independent Director >HSIC

29 Jan 2025, 12:02 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

29 Jan 2025, 12:02 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

29 Jan 2025, 12:01 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

29 Jan 2025, 12:00 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

29 Jan 2025, 12:00 UTC

Earnings
Acquisitions, Mergers, Takeovers

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

29 Jan 2025, 10:30 UTC

Top News
Acquisitions, Mergers, Takeovers

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

29 Jan 2025, 10:30 UTC

Acquisitions, Mergers, Takeovers

Henry Schein Has Already Been an Activist Target -- WSJ

29 Jan 2025, 10:30 UTC

Acquisitions, Mergers, Takeovers

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

29 Jan 2025, 10:30 UTC

Acquisitions, Mergers, Takeovers

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Peer Comparison

Price change

Henry Schein Inc Forecast

Price Target

By TipRanks

6.02% upside

12 Months Forecast

Average 81.89 USD  6.02%

High 90 USD

Low 74 USD

Based on 9 Wall Street analysts offering 12 month price targets forHenry Schein Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

9 ratings

2

Buy

7

Hold

0

Sell

Technical Score

By Trading Central

77.2 / 77.48Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

109 / 393 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.